Latest news

PCI Biotech to present at Biotech Showcase 2018

Posted on Jan 8, 2018

Oslo, Norway, January 8, 2017 – PCI Biotech (OSE:PCIB), a clinical-stage company developing innovative therapeutics that address significant unmet medical needs, today announced that it will present at Biotech Showcase 2018 being held January 8-10, 2018 at the Hilton San Francisco Union Square, California, US. On Tuesday, January 9, 2019 at 04:00pm (PST), Dr. Per Walday, […]

PCI Biotech announces preliminary outcome of meetings with EMA and FDA for development of fimaporfin in inoperable cholangiocarcinoma

Posted on Dec 20, 2017

Oslo, 20 December 2017 – PCI Biotech (OSE: PCIB), a cancer focused biopharmaceutical company, today announced preliminary outcome of regulatory interactions with the European Medicines Agency (EMA) and the U.S. Food and Drug Administration (FDA) on the development of fimaporfin in combination with gemcitabine for treatment of inoperable cholangiocarcinoma (bile duct cancer). The purpose of […]

Third quarter 2017 report and presentation

Posted on Nov 28, 2017

Oslo, 28 November 2017 – Please find enclosed the financial report and presentation for third quarter 2017. PCI Biotech Q3 2017 Report PCI Biotech Q3 2017 Presentation Granting of orphan status from the FDA was an important milestone for the fimaCHEM programme during Q3 2017, as was the inclusion of the first patient in the […]